<DOC>
	<DOCNO>NCT00004826</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine efficacy tolerability clozapine ameliorate psychosis patient idiopathic Parkinson 's disease ( PD ) . II . Determine adverse effect clozapine motor function patient population . III . Determine safety clozapine psychotic PD patient take multiple anti-PD medication . IV . Describe phenomenology drug induce psychosis PD .</brief_summary>
	<brief_title>Study Clozapine Treatment Psychosis Patients With Idiopathic Parkinson 's Disease</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , placebo control , double blind study , follow open label treatment patient . Patients stratify accord institutional investigator age . In first phase study , patient receive either clozapine placebo . The drug take orally night , approximately 30 minute retire . Therapy continue 4 week unless psychosis become unmanageable without hospitalization , parkinsonism worsens , adverse effect occur . It possible dose may escalate . In second phase study , patient treat open label clozapine . Therapy continue 3 month unless psychiatric status parkinsonism progress . Dose escalation also possible phase . Patients follow weekly first phase study , monthly second phase . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Presumed idiopathic Parkinson 's disease Presence three cardinal feature : Rest tremor Rigidity Bradykinesias/akinesia Postural balance abnormality Absence alternative explanation syndrome Absence atypical feature Psychosis least 4 week duration require treatment Prior/Concurrent Therapy Chemotherapy : No concurrent chemotherapy Other : No use dopamine block drug within past 3 month No use depot neuroleptic within past 12 month No change antidepressant anxiolytic dose within past 1 month No prior clozapine psychosis AntiPD medication stable least 7 day study entry Patient Characteristics Hematopoietic : No history leukopenia No active blood dyscrasia mild anemia Renal : No active problem urinary retention Cardiovascular : No symptomatic orthostatic hypotension No uncontrolled angina No myocardial infarction within past 3 month Other : Fertile patient must use effective contraception No uncontrolled seizure ( i.e. , 1 seizure per month past 6 month ) No dementia preclude accurate assessment psychiatric assessment battery No AIDS No illness would make use clozapine potentially hazardous No narrow angle glaucoma No systemic factor contribute psychosis ( e.g. , urinary infection , liver disease , renal failure , anemia , infection , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1998</verification_date>
	<keyword>Parkinson disease</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>